The ups and downs of multiple sclerosis therapeutics
- PMID: 11261499
The ups and downs of multiple sclerosis therapeutics
Comment on
-
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group.Ann Neurol. 2001 Mar;49(3):290-7. Ann Neurol. 2001. PMID: 11261502 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
